Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

986 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
PSYSCAN multi-centre study: baseline characteristics and clinical outcomes of the clinical high risk for psychosis sample.
Tognin S, Vieira S, Oliver D, Cullen AE, Kempton MJ, Fusar-Poli P, Mechelli A, Dazzan P, Merritt K, Maat A, de Haan L, Lawrie SM, van Amelsvoort T, Arango C, Nelson B, Galderisi S, Bressan R, Kwon JS, Mizrahi R; PSYSCAN Consortium; Kahn RS, McGuire P. Tognin S, et al. Schizophrenia (Heidelb). 2025 Apr 17;11(1):66. doi: 10.1038/s41537-025-00598-x. Schizophrenia (Heidelb). 2025. PMID: 40246889 Free PMC article.
Proteome-wide microarray-based screening of PAR-binding proteins.
Gu Kang B, Kang SU, Jin Kim J, Kwon JS, Gagné JP, Yun Lee S, Kim S, Lee KS, Ha S, Seop Jeong J, Lee YI, Zhu H, Kim D, Poirier GG, Chul Kang H, Dawson VL, Dawson TM. Gu Kang B, et al. Nucleic Acids Res. 2025 Apr 10;53(7):gkaf300. doi: 10.1093/nar/gkaf300. Nucleic Acids Res. 2025. PMID: 40239998 Free PMC article.
Sample ascertainment and clinical outcome measures in the Accelerating Medicines Partnership® Schizophrenia Program.
Addington J, Liu L, Braun A, Auther A, Calkins ME, Cornblatt BA, Corcoran CM, Fusar-Poli P, Kerr MJ, Mourgues-Codern CV, Nunez AR, Oliver D, Strauss GP, Walsh BC, Alameda LK, Arango C, Breitborde NJK, Broome MR, Cadenhead KS, Carrion RE, Chen EYH, Choi J, Coleman MJ, Conus P, Diaz-Caneja CM, Dwyer D, Ellman LM, Faghankhani M, Gaspar PA, Gerber C, Glenthøj LB, Horton LE, Hui C, Jacobs GR, Kambeitz J, Kambeitz-Ilankovic L, Keshavan MS, Kim SW, Koutsouleris N, Kwon JS, Langbein K, Lewandowski KE, Mamah D, Marcy PJ, Mathalon DH, Mittal VA, Nordentoft M, Pearlson GD, Penzel N, Perez J, Perkins DO, Powers AR 3rd, Rogers J, Sabb FW, Schiffman J, Shah JL, Silverstein SM, Smesny S, Stone WS, Thompson A, Thompson JL, Upthegrove R, Verma S, Wang J, Wastler HM, Wickham A, Rossum IW, Wolf DH, Bouix S, Pasternak O, Kahn RS, Bearden CE, Kane JM, McGorry PD, Buccilli K, Nelson B, Shenton ME, Woods SW; Accelerating Medicines Partnership® -Schizophrenia; Yung AR. Addington J, et al. Schizophrenia (Heidelb). 2025 Apr 3;11(1):54. doi: 10.1038/s41537-025-00556-7. Schizophrenia (Heidelb). 2025. PMID: 40180953 Free PMC article.
Data analysis strategies for the Accelerating Medicines Partnership® Schizophrenia Program.
Penzel N, Polosecki P, Addington J, Arango C, Asgari-Targhi A, Billah T, Bouix S, Calkins ME, Campbell DE, Cannon TD, Castro E, Cho KIK, Coleman MJ, Corcoran CM, Dwyer D, Frangou S, Fusar-Poli P, Glynn RJ, Haidar A, Harms MP, Jacobs GR, Kambeitz J, Kapur T, Kelly SM, Koutsouleris N, Abhinandan KR, Kucukemiroglu S, Kwon JS, Lewandowski KE, Li QS, Mantua V, Mathalon DH, Mittal VA, Nicholas S, Pandina GJ, Perkins DO, Potter A, Reichenberg A, Reinen J, Sand MS, Seitz-Holland J, Shah JL, Srinivasan V, Srivastava A, Stone WS, Torous J, Vangel MG, Wang J, Wolff P, Yao B, Anticevic A, Wolf DH, Zhu H, Bearden CE, McGorry PD, Nelson B, Kane JM, Woods SW, Kahn RS, Shenton ME; Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ); Cecchi G, Pasternak O. Penzel N, et al. Schizophrenia (Heidelb). 2025 Apr 3;11(1):53. doi: 10.1038/s41537-025-00561-w. Schizophrenia (Heidelb). 2025. PMID: 40180950 Free PMC article.
INTEGRATE: international guidelines for the algorithmic treatment of schizophrenia.
McCutcheon RA, Pillinger T, Varvari I, Halstead S, Ayinde OO, Crossley NA, Correll CU, Hahn M, Howes OD, Kane JM, Kabir T, Konradsson-Geuken Å, Lennox B, Hui CLM, Rossell SL, Solmi M, Sommer IE, Taipale H, Uchida H, Venkatasubramanian G, Warren N; INTEGRATE Advisory Group; Siskind D. McCutcheon RA, et al. Lancet Psychiatry. 2025 May;12(5):384-394. doi: 10.1016/S2215-0366(25)00031-8. Epub 2025 Mar 31. Lancet Psychiatry. 2025. PMID: 40179920 Review.
The MR neuroimaging protocol for the Accelerating Medicines Partnership® Schizophrenia Program.
Harms MP, Cho KK, Anticevic A, Bolo NR, Bouix S, Campbell D, Cannon TD, Cecchi G, Goncalves M, Haidar A, Hughes DE, Izyurov I, John O, Kapur T, Kim N, Kotler E, Kubicki M, Kuperman JM, Laulette K, Lindberg U, Markiewicz C, Ning L, Poldrack RA, Rathi Y, Romo PA 3rd, Tamayo Z, Wannan C, Wickham A, Yassin W, Zhou JH, Addington J, Alameda L, Arango C, Breitborde NJK, Broome MR, Cadenhead KS, Calkins ME, Chen EYH, Choi J, Conus P, Corcoran CM, Cornblatt BA, Diaz-Caneja CM, Ellman LM, Fusar-Poli P, Gaspar PA, Gerber C, Glenthøj LB, Horton LE, Hui CLM, Kambeitz J, Kambeitz-Ilankovic L, Keshavan MS, Kim SW, Koutsouleris N, Kwon JS, Langbein K, Mamah D, Mathalon DH, Mittal VA, Nordentoft M, Pearlson GD, Perez J, Perkins DO, Powers AR 3rd, Rogers J, Sabb FW, Schiffman J, Shah JL, Silverstein SM, Smesny S, Stone WS, Strauss GP, Thompson JL, Upthegrove R, Verma SK, Wang J, Wolf DH, Kahn RS, Kane JM, McGorry PD, Nelson B, Woods SW, Shenton ME, Wood SJ, Bearden CE; Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ); Pasternak O. Harms MP, et al. Schizophrenia (Heidelb). 2025 Apr 2;11(1):52. doi: 10.1038/s41537-025-00581-6. Schizophrenia (Heidelb). 2025. PMID: 40175382 Free PMC article.
Cognitive assessment in the Accelerating Medicines Partnership® Schizophrenia Program: harmonization priorities and strategies in a diverse international sample.
Allott K, Yassin W, Alameda L, Billah T, Borders O, Buccilli K, Carrión RE, Castillo-Passi RI, Cho KIK, Chin K, Coleman MJ, Colton BL, Corral S, Dwyer D, Gundersen KB, Gur RC, Hoftman GD, Jacobs GR, Kelly S, Lewandowski KE, Marcy PJ, Matneja P, McLaughlin D, Nunez AR, Parsa S, Penzel N, Ray S, Reinen JM, Ruparel K, Sand MS, Santorelli G, Seitz-Holland J, Spark J, Tamayo Z, Thompson A, Tod S, Wannan CMJ, Wickham A, Wood SJ, Zoupou E, Addington J, Anticevic A, Arango C, Breitborde NJK, Broome MR, Cadenhead KS, Calkins ME, Chen EYH, Choi J, Conus P, Corcoran CM, Cornblatt BA, Ellman LM, Fusar-Poli P, Gaspar PA, Gerber C, Glenthøj LB, Horton LE, Hui CLM, Kambeitz J, Kambeitz-Ilankovic L, Keshavan M, Kim SW, Koutsouleris N, Kwon JS, Langbein K, Mamah D, Diaz-Caneja CM, Mathalon DH, Mittal VA, Nordentoft M, Pearlson GD, Perkins DO, Perez J, Powers AR 3rd, Rogers J, Sabb FW, Schiffman J, Shah JL, Silverstein SM, Smesny S, Strauss GP, Thompson JL, Upthegrove R, Verma SK, Wang J, Wolf DH, Pasternak O, Bouix S, McGorry PD, Kane JM, Kahn RS, Bearden CE, Shenton ME, Woods SW, Nelson B; Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ); Stone WS. Allott K, et al. Schizophrenia (Heidelb). 2025 Mar 24;11(1):49. doi: 10.1038/s41537-025-00578-1. Schizophrenia (Heidelb). 2025. PMID: 40128256 Free PMC article.
986 results